Blueshift Asset Management, LLC Seagen Inc. Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$108.81 - $179.33 $48,529 - $79,981	-446 Reduced 20.48%	1,732 $306,000
Q1 2022 May 12, 2022	SELL	$119.61 - $157.85 $805,094 - $1.06 Million	-6,731 Reduced 75.55%	2,178 $314,000
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $177,784 - $238,002	1,247 Added 16.28%	8,909 $1.38 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $538,176 - $641,579	3,778 Added 97.27%	7,662 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $352,153 - $419,987	-2,607 Reduced 40.16%	3,884 $613,000
Q1 2021 May 06, 2021	BUY	$137.51 - $190.8 $892,577 - $1.24 Million	6,491 New	6,491 $901,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.